vTv Therapeutics

VTVT

Market cap $122M

VTVT Hedge Fund Activity: Q1 2026 in Review

35 of the 8,131 institutional investors tracked by Wall St. Rank reported a position in vTv Therapeutics (VTVT) for Q1 2026, worth a combined $59M — up 15% from $51.3M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new VTVT positions and 3 closed out — a net gain of 9 holders — while 7 added to existing stakes and 4 trimmed.

The largest buyer was Millennium Management, opening a new position worth an estimated $7.49M. The largest seller was Trails Edge Capital Partners, cutting an estimated $3.32M.

• 35 institutional investors held vTv Therapeutics (VTVT) as of Q1 2026, up from 27 in Q4 2025.
• Funds reported $59M of vTv Therapeutics stock for Q1 2026, up 15% quarter-over-quarter.
• 12 funds opened new vTv Therapeutics positions in Q1 2026 and 3 closed out, a net change of +9 holders.
• The largest vTv Therapeutics buyer in Q1 2026 was Millennium Management, an estimated $7.49M added.
• The largest vTv Therapeutics seller in Q1 2026 was Trails Edge Capital Partners, an estimated $3.32M sold.

Based on aggregated 13F filings for Q1 2026.